Cowen & Co.'s Washington Strategist Chris Krueger and Prevision Policy's Ramsey Baghdadi talk about the initial strategy behind the House AHCA bill, whether it will be revisited, the impact on user fee legislation and whether there is room for drug pricing in the upcoming legislative period.